Search results
Ainos advances AI Nose tech in clinical trials By Investing.com
Investing.com· 1 day ago:AIMD, AIMDW), a healthcare company specializing in AI-powered point-of-care testing and...
Neogen's (NEOG) MDS Secures New Contract From USDA FSIS
Zacks via Yahoo Finance· 2 days agoNeogen's (NEOG) MDS gets recognized by the USDA FSIS as the primary method for the detection of...
AI Transforms Sepsis Care With Faster, More Effective Treatments
SciTechDaily· 1 day agoResearchers at Day Zero Diagnostics have developed Keynome gAST, an AI-driven genomic Antimicrobial...
Legionella Testing Market size is set to grow by USD 167.3 million from 2024-2028, Rise in geriatric...
Benzinga· 3 days agoNEW YORK, June 12, 2024 /PRNewswire/ -- The global legionella testing market size is estimated to grow by USD 167.3 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.09%
Artillery goes trucking to survive drones swarming the battlefield
Defense News via Yahoo News· 3 days agoRussian military bloggers on Telegram in April described the Caesar’s range, accuracy and mobility,...
Melbourne, FL Gutter Repair & Installation: Site Inspection & Maintenance Update
Digital Journal· 1 day agoGreat care is taken by the team to ensure accuracy as even the smallest miscalculations can lead to overflows and property damage. The same...
Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA...
Digital Journal· 1 day agoClinical trials for AI Nose-powered Ainos Flora device moves forward with 75 meaningful case results, paving the way for next-gen product targeting at-home testingNext-Gen Ainos Flora will advance ...
Council Post: 14 Emerging Wearable Health Technologies Transforming Remote Care
Forbes· 5 days agoFrom continuous glucose monitors to smartwatches with advanced health metrics, these innovations are...
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput...
Morningstar· 2 days agoVenlo, the Netherlands, and Redwood City, California, June 13, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the release of a new version of its clinical decision support software, QIAGEN Clinical Insight
Running AI and edge workloads on CPUs
The Register· 5 days agoPartner Content Power and cooling in datacenters for well over a decade have been a challenge for enterprises trying to meet their compute needs while...